DAXXIFY
- Product NDC
- 72960-112
- 11-digit product format
- 729600112
- Labeler code
- 72960
- Product ID
- 72960-112_71c76e28-0eb6-487e-a53b-4c9e78021e57
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- botulinum toxin type A
- Dosage form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Route
- INTRAMUSCULAR
- Labeler
- Revance Therapeutics, Inc.
- Application
- BLA761127
- Marketing category
- BLA
- Marketing start
- 2022-09-20
- Substance
- BOTULINUM TOXIN TYPE A
- Active strength
- 100 U/1.2mL
- Pharmacologic classes
- Acetylcholine Release Inhibitor [EPC], Acetylcholine Release Inhibitors [MoA], Neuromuscular Blockade [PE], Neuromuscular Blocker [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- DAXXIFY
- Listing expiration
- 2027-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| BOTULINUM TOXIN TYPE A | 100 U/1.2mL |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | E211KPY694 |
| Rxcui | 2612454, 2612456 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 72960-112-01 | DAXXIFY | 1 in 1 CARTON | INJECTION, POWDER, LYOPHILIZED, | 1 | | 12 |
| 72960-112-01 | DAXXIFY | 1.2 mL in 1 VIAL, SINGLE-USE | INJECTION, POWDER, LYOPHILIZED, | 1.2 | | 12 |
| 72960-112-02 | DAXXIFY | 1.2 mL in 1 VIAL, SINGLE-USE | INJECTION, POWDER, LYOPHILIZED, | 1.2 | | 12 |
| 72960-112-02 | DAXXIFY | 1 in 1 CARTON | INJECTION, POWDER, LYOPHILIZED, | 1 | | 12 |
| 72960-112-05 | DAXXIFY | 1 in 1 CARTON | INJECTION, POWDER, LYOPHILIZED, | 1 | | 12 |
| 72960-112-05 | DAXXIFY | 1.2 mL in 1 VIAL, SINGLE-USE | INJECTION, POWDER, LYOPHILIZED, | 1.2 | | 12 |
| 72960-112-06 | DAXXIFY | 1 in 1 CARTON | INJECTION, POWDER, LYOPHILIZED, | 1 | | 12 |
| 72960-112-06 | DAXXIFY | 1.2 mL in 1 VIAL, SINGLE-USE | INJECTION, POWDER, LYOPHILIZED, | 1.2 | | 12 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 72960-112 | DAXXIFY (BOTULINUM TOXIN TYPE A) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [REVANCE THERAPEUTICS, INC.] | 10 | Current NDC, Legacy NDC, 8 package rows | 20240202_3aaa6e14-a3f7-4fb2-b9f9-d3a9c3ae1f74.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 72960-112-01 | 72960011201 | 1 VIAL, SINGLE-USE in 1 CARTON (72960-112-01) / 1.2 mL in 1 VIAL, SINGLE-USE | 2022-09-20 | 0000-00-00 | No | No | Current |
| 72960-112-02 | 72960011202 | 1 VIAL, SINGLE-USE in 1 CARTON (72960-112-02) / 1.2 mL in 1 VIAL, SINGLE-USE | 2022-09-20 | | Yes | No | Current |
| 72960-112-05 | 72960011205 | 1 in 1 CARTON | | | | | Historical |
| 72960-112-06 | 72960011206 | 1 in 1 CARTON | | | | | Historical |